• Explore /
  • Poster
  • / Neoadjuvant combined chemotherapy and immunotherapy for upper tract urothelial carcinoma: Preliminary results from a phase II study.

Neoadjuvant combined chemotherapy and immunotherapy for upper tract urothelial carcinoma: Preliminary results from a phase II study.

Abstract Poster

Authors

null

Xin-Gang Bi

Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 2 Department of Med, Beijing, China

Xin-Gang Bi , Wen Zhang , Yaoyu Xie , Jie Wu , Honglei Cui , Chuanzhen Cao , Li Lu , Li Wen , Youyan Guan , Hongzhe Shi , Zhendong Xiao , Zhichao Jiang , Yongkun Sun , Shan Zheng , Jin Zhang , Aiping Zhou , Jianzhong Shou

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04099589

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 636)

DOI

10.1200/JCO.2024.42.4_suppl.636

Abstract #

636

Poster Bd #

H21

Abstract Disclosures

Similar Posters

First Author: Yali Shen

First Author: Zhigang Liu

First Author: Qiu-Yan Chen

First Author: Hongsik Kim